SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: arnie h who wrote (874)8/10/1999 7:30:00 PM
From: Zvi Steinberg  Read Replies (2) of 1386
 
Some news on Pharmos:

1. Spoke with Gale Smith, Pharmos IR. The annual shareholders meeting will take place in NYC, Oct. 13, 1999, at the Intercontinental Hotel, starting around 4-4:30 PM. Details will be available with the proxy materials.

2. Gale and others are working hard on getting exposure for Pharmos through various media. The web page will be completely renovated and up to date.

3. Sturza's latest assessment of Pharmos (8/5/99) is a BUY recommendation -- no price target -- but cautions that share price will remain sluggish until partnership or profitability. They continue to believe that PARS current valuation does not reflect the potential of currently marketed products nor the development pipeline. In short, a cautiously optimistic and positive review.

As the saying goes, "It takes patience to pick roses".
Zvi
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News